National Resilience

Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can be produced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.